Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Physiomics shares jump on new contract wins

(Sharecast News) - Shares in Physiomics surged on Thursday after the mathematical modelling company was awarded two contracts, one of which was with a new client.

The group, which supports the development of oncology drugs and personalised medicine solutions, has won its first contract with a new unnamed biotech client in the UK. The contract, worth £125,000, relates to a project in the immune-oncology field, is expected to be completed within this calendar year.

Separately, Physiomics also announced it had won a further contract with existing client Merck for an undisclosed amount. The work, which should complete over the next three months, involves "pre-clinical and clinical modelling and simulation of anti-cancer regimens involving combinations of DNA damage/ repair agents", the company said.

Physiomics has now announced four contract awards in August alone.

The stock was up 21% at 1.18p in afternoon trade.

Share this article

Related Sharecast Articles

S4 Capital FY revenues expected to fall 'low double digits'
(Sharecast News) - Marketing firm S4 Capital warned on revenues on Thursday amid ongoing economic challenges.
Lords Group acquires majority stake in Ultimate Renewables
(Sharecast News) - Building materials distributor Lords Group said on Monday that it has acquired a majority stake in Bicester-based business Ultimate Renewables.
Record assets under management grow in Q2
(Sharecast News) - Currency and asset manager Record said on Friday that assets under management had grown in the three months ended 30 September.
Van Elle secures 'strategically important contracts' with ONxpress
(Sharecast News) - Ground engineering contractor Van Elle's Canadian rail subsidiary has been awarded two "strategically important contracts" by ONxpress.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.